HK143195A - Purified follicle stimulating hormone - Google Patents

Purified follicle stimulating hormone

Info

Publication number
HK143195A
HK143195A HK143195A HK143195A HK143195A HK 143195 A HK143195 A HK 143195A HK 143195 A HK143195 A HK 143195A HK 143195 A HK143195 A HK 143195A HK 143195 A HK143195 A HK 143195A
Authority
HK
Hong Kong
Prior art keywords
stimulating hormone
follicle stimulating
purified follicle
purified
hormone
Prior art date
Application number
HK143195A
Other languages
English (en)
Inventor
Giuseppe Arpaia
Serenella Serani
Antonino Sirna
Stefano Villa
Original Assignee
Serono Cesare Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11264576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK143195(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serono Cesare Ist Ricerca filed Critical Serono Cesare Ist Ricerca
Publication of HK143195A publication Critical patent/HK143195A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK143195A 1987-06-26 1995-09-07 Purified follicle stimulating hormone HK143195A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8748110A IT1206302B (it) 1987-06-26 1987-06-26 Ormone follicolo-stimolante urinario

Publications (1)

Publication Number Publication Date
HK143195A true HK143195A (en) 1995-09-15

Family

ID=11264576

Family Applications (1)

Application Number Title Priority Date Filing Date
HK143195A HK143195A (en) 1987-06-26 1995-09-07 Purified follicle stimulating hormone

Country Status (26)

Country Link
US (3) US5128453A (it)
EP (1) EP0322438B1 (it)
JP (1) JP2523843B2 (it)
KR (1) KR0156565B1 (it)
CN (2) CN1031714C (it)
AR (1) AR243241A1 (it)
AT (1) ATE115148T1 (it)
AU (1) AU615930B2 (it)
CA (1) CA1340649C (it)
DE (1) DE3852383T2 (it)
DK (1) DK173349B1 (it)
ES (1) ES2009948A6 (it)
FI (1) FI96608C (it)
GE (2) GEP19971042B (it)
GR (1) GR1003186B (it)
HK (1) HK143195A (it)
IL (1) IL86847A (it)
IT (1) IT1206302B (it)
LT (2) LT3999B (it)
LV (2) LV10628B (it)
MX (1) MX9203471A (it)
NO (1) NO177498C (it)
RU (2) RU2105012C1 (it)
UA (1) UA19101A (it)
WO (1) WO1988010270A1 (it)
ZA (1) ZA884492B (it)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1270866B (it) * 1993-03-10 1997-05-13 Eniricerche Spa Vettore ricombinante e suo impiego per la preparazione esocellulare di anticorpi in forma di singola molecola da bacillus subtilis
US6737515B2 (en) * 1993-11-19 2004-05-18 Washington University Follicle stimulating hormone-glycosylation analogs
US6162905A (en) * 1996-11-07 2000-12-19 Ibsa Institut Biochimique S.A. FSH and LH separation and purification process
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US5990288A (en) * 1997-10-21 1999-11-23 Vitro Diagnostics, Inc. Method for purifying FSH
US6414123B1 (en) 1997-10-21 2002-07-02 Vitro Diagnostics, Inc. Method for purifying FSH
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
IL140984A0 (en) * 1998-07-23 2002-02-10 Lilly Co Eli Fsh and fsh variant formulations, products and methods
AU779869B2 (en) 1999-04-13 2005-02-17 Nektar Therapeutics Pulmonary administration of dry powder formulations for treating infertility
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
EP1282418B1 (en) * 2000-05-19 2005-08-17 Applied Research Systems ARS Holding N.V. Use of pyrazole derivatives for treating infertility
ES2281458T3 (es) * 2000-12-21 2007-10-01 Nektar Therapeutics Composiciones de polvo estables en almacenamiento del receptor de interleucina 4.
AU2002368265B2 (en) 2001-10-22 2007-06-07 Merck Serono Sa Mutant glycoproteins
DK1438336T3 (da) * 2001-10-22 2006-10-02 Applied Research Systems Gonadotropiner til follikeldannelse
JP4713152B2 (ja) * 2002-09-20 2011-06-29 メルク セローノ ソシエテ アノニム ピペラジン誘導体及び使用方法
BRPI0409229A (pt) * 2003-04-01 2006-03-28 Applied Research Systems inibidores das fosfodiesterases na infertilidade
MXPA05010635A (es) * 2003-04-02 2005-12-12 Ares Trading Sa Formulaciones farmaceuticas liquidas de hormona estimulante de foliculos y hormona luteinizante junto con un surfactante no ionico.
ES2414705T3 (es) * 2003-06-20 2013-07-22 Ares Trading S.A. Formulaciones liofilizadas de FSH/LH
JP4763616B2 (ja) * 2003-12-22 2011-08-31 アレス トレーディング ソシエテ アノニム Ｆｓｈを精製するための方法
US20070270339A1 (en) * 2004-04-23 2007-11-22 Serono, Inc. Use of GPCR54 Ligands for the Treatment of Infertility
PL1809663T3 (pl) 2004-11-09 2009-01-30 Ares Trading Sa Sposób oczyszczania FSH
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
LT1917276T (lt) 2005-08-26 2018-05-25 Ares Trading S.A. Glikozilinto interferono beta gavimo būdas
EA200800755A1 (ru) 2005-09-07 2008-10-30 Лаборатуар Сероно С.А. Ikk ингибиторы, предназначенные для лечения эндометриоза
EP1951395B1 (en) * 2005-09-14 2012-02-29 Ares Trading S.A. Method for the quantitative determination of poloxamers
AU2006323925B2 (en) 2005-12-09 2012-08-02 Ares Trading S.A. Method for purifying FSH or a FSH mutant
AU2008279584A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
US8318457B2 (en) 2007-06-28 2012-11-27 Biogenerix Ag FSH producing cell clone
EA019530B1 (ru) 2008-02-08 2014-04-30 Биодженерикс Аг Жидкая лекарственная форма фсг
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
JP2009273427A (ja) 2008-05-16 2009-11-26 Jcr Pharmaceuticals Co Ltd 組換え体ヒトｆｓｈの製造方法
KR101761168B1 (ko) 2009-04-01 2017-07-25 바이오제너릭스 게엠베하 재조합 ｆｓｈ 정제 방법
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
CA3163525A1 (en) 2011-03-31 2012-10-04 Ferring Bv. Pharmaceutical preparation
CN103509121B (zh) 2012-11-22 2015-01-28 苏州康宁杰瑞生物科技有限公司 一种fsh融合蛋白及其制备方法和用途
US10537723B2 (en) 2014-09-11 2020-01-21 Hisamitsu Pharmaceutical Co., Inc. Microneedle device
JP6621754B2 (ja) 2014-10-27 2019-12-18 久光製薬株式会社 遺伝子組換型卵胞刺激ホルモンを含有するマイクロニードルデバイス
KR102636093B1 (ko) * 2016-10-11 2024-02-13 온코그린 테라퓨틱스 에스아 종양의 진단 및 치료에서 fsh 호르몬 수용체의 리간드
CN111349154A (zh) * 2018-12-21 2020-06-30 江苏众红生物工程创药研究院有限公司 一种重组人促卵泡激素及其制备方法和药物应用
KR20210083173A (ko) * 2019-12-26 2021-07-06 주식회사 엘지화학 여포 자극 호르몬의 정제 방법
CN113583125B (zh) * 2021-07-09 2022-09-20 苏州晟济药业有限公司 抗体以及包含其的结合剂、免疫吸附材料及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852422A (en) * 1971-06-26 1974-12-03 Serono Ist Farm Long-active gonadotropins
SU618113A1 (ru) * 1976-11-19 1978-08-05 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Способ получени фолликулостимулирующего гормона
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
ATE65407T1 (de) * 1984-04-03 1991-08-15 Serono Lab Verfahren zur herbeifuehrung der ovulation.
GB8510177D0 (en) * 1985-04-22 1985-05-30 Public Health Laborotory Servi Isolating pituitary glycoprotein hormones
GB2174600B (en) * 1985-05-10 1989-12-20 Univ Melbourne Induction of ovulation in mares
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario

Also Published As

Publication number Publication date
NO177498B (no) 1995-06-19
FI96608B (fi) 1996-04-15
KR890701626A (ko) 1989-12-21
FI890893A (fi) 1989-02-24
CA1340649C (en) 1999-07-13
LTIP1652A (en) 1995-08-25
IT1206302B (it) 1989-04-14
WO1988010270A1 (en) 1988-12-29
DK89989D0 (da) 1989-02-24
LT4018B (en) 1996-08-26
AR243241A1 (es) 1993-07-30
GEP19981274B (en) 1998-05-06
CN1069062C (zh) 2001-08-01
DK89989A (da) 1989-02-24
DE3852383T2 (de) 1995-04-20
CN1117873A (zh) 1996-03-06
RU2105012C1 (ru) 1998-02-20
DK173349B1 (da) 2000-08-07
DE3852383D1 (de) 1995-01-19
MX9203471A (es) 1992-09-01
LV10628B (en) 1995-10-20
LTIP1654A (en) 1995-08-25
LV10628A (lv) 1995-04-20
LT3999B (en) 1996-06-25
AU1962088A (en) 1989-01-19
GR1003186B (el) 1999-09-01
US5767067A (en) 1998-06-16
JP2523843B2 (ja) 1996-08-14
RU2059412C1 (ru) 1996-05-10
JPH02500840A (ja) 1990-03-22
GEP19971042B (en) 1997-06-13
NO890805L (no) 1989-02-24
EP0322438B1 (en) 1994-12-07
FI96608C (fi) 1996-07-25
IL86847A (en) 1997-11-20
LV10196B (en) 1995-04-20
IT8748110A0 (it) 1987-06-26
GR880100418A (el) 1989-03-08
ES2009948A6 (es) 1989-10-16
IL86847A0 (en) 1988-11-30
FI890893A0 (fi) 1989-02-24
US5128453A (en) 1992-07-07
NO890805D0 (no) 1989-02-24
US5840857A (en) 1998-11-24
ZA884492B (en) 1989-05-30
CN1031714C (zh) 1996-05-01
AU615930B2 (en) 1988-06-24
CN1030589A (zh) 1989-01-25
LV10196A (lv) 1994-10-20
EP0322438A1 (en) 1989-07-05
KR0156565B1 (ko) 1998-10-15
ATE115148T1 (de) 1994-12-15
NO177498C (no) 1995-09-27
UA19101A (uk) 1997-12-25

Similar Documents

Publication Publication Date Title
HK143195A (en) Purified follicle stimulating hormone
GB2188234B (en) Therapeutic agents
NZ223827A (en) Skin substitute
YU67987A (en) Flat therapeutic system
CY1833A (en) Therapeutic nucleosides
PT86573A (en) Therapeutic preparations
EP0286425A3 (en) Therapeutic nucleosides
NZ224281A (en) Crystalline human proinsulin
ZA904748B (en) Ovine follicle stimulating hormone
GB8725427D0 (en) Somatotropin formulations
AP8800085A0 (en) Therapeutic nucleosides
EP0274696A3 (en) Ambulance
ZA887364B (en) Ovulation treatment
GR880100417A (en) Urinary follicle stimulating hormone
GB8626296D0 (en) Therapeutic agents
GB8603447D0 (en) Therapeutic compounds
JPS6410000A (en) Human splenine
GB8629663D0 (en) Therapeutic agents
GB8619897D0 (en) Therapeutic method
HUT50029A (en) Operating-table
BG43937A1 (en) Setting solution
ZA8846B (en) Therapeutic preparations
GB8719038D0 (en) Therapeutic method
GB8617347D0 (en) Therapeutic agents
GB8617345D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080623